Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
March 28, 2024
Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of ...
Blog Post
April 24, 2023
As World Immunization Week kicks off today, childhood vaccination remains among the most cost-effective uses of health spending. Significant progress has been made to expand global vaccine coverage. Yet, rates remain inequitable and highly variable—within countries but also across those in the same ...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
Blog Post
February 23, 2023
How can we ensure that medical countermeasures—such as diagnostics and vaccines—are ready to go at local, national, and global levels when the next pandemic emerges? Amanda Glassman speaks with Dr. Amadou Alpha Sall of Institut Pasteur of Dakar and Dr. Rachel Glennerster of the University of Chicago...
Blog Post
February 13, 2023
During this long period of leadership stability, there has been enormous growth in Gavi’s funding and staffing, even through the stormy waters of COVID-19, with enough vaccines delivered to legitimately claim millions of lives saved. Dr. Pate will arrive with a strong financial base, the ability to ...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...